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Abstract
Disruption of p53/Puma-mediated apoptosis protects against lethality due to DNA damage. Here we demonstrate the
unexpected requirement of the pro-apoptotic p53-target gene Puma to mount a successful innate immune response to
bacterial sepsis. Puma
2/2 mice rapidly died when challenged with bacteria. While the immune response in Puma
2/2 mice
was unchanged in cell migration, phagocytosis and bacterial killing, sites of infection accumulated large abscesses and
sepsis was progressive. Blocking p53/Puma-induced apoptosis during infection caused resistance to ROS-induced cell death
in the CD49d+ neutrophil subpopulation, resulting in insufficient immune resolution. This study identifies a biological role
for p53/Puma apoptosis in optimizing neutrophil lifespan so as to ensure the proper clearance of bacteria and exposes a
counter-balance between the innate immune response to infection and survival from DNA damage.
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Introduction
Programmed cell death is critical to the course of natural
development and for the elimination of potentially abnormal cells
that have encountered various stresses such as DNA damage,
oncogene overexpression or hypoxia [1]. During cellular stress, the
p53 tumor suppressor protein blocks cell cycle progression
allowing time to repair the damage [2,3] or induces apoptosis
largely through the upregulation of the Bcl-2 family BH3-only
protein Puma (p53 upregulated modulator of apoptosis) [4–6]. In
the absence of p53/Puma-induced cell death, animals and primary
cell cultures demonstrate remarkable resistance to apoptosis
following DNA damage, glucocorticoid treatment, and cytokine
withdrawal [7–9]. Despite this survival advantage, Puma is
maintained in the genome suggesting the existence of a strongly
positive, counteracting selective pressure. We hypothesized that
one such ubiquitous selective pressure might arise in the context of
infection. During infection, apoptosis has generally been regarded
as a consequence of cellular injury. For instance, bacterial-induced
apoptosis is a major determinant of cellular and organ injury
during infections of the brain and gut [10,11] and inhibition of
apoptosis improves residual organ function in survivors [12,13].
Clinical trials have indicated that sequelae of bacterial meningitis
are mitigated by pharmacological inhibition of bacterial-induced
neuronal apoptosis [14]. Conversely, widespread apoptosis of
phagocytic cells, as seen with chemotherapy, impairs control of an
infection [15,16]. These results would suggest that loss of p53 or
Puma would potentially benefit outcome of infection by preserving
host cells and organ function. However, there are some suggestions
that blocking apoptosis is not universally beneficial in the context
of infection. Inhibition of iNOS was associated with decreased
macrophage apoptosis but increased mortality in bacterial
pneumonia [17]. In septic mice, absence of p53 decreased
apoptosis but accelerated mortality in one study [18] while no
effect on outcome was seen in another [19]. Active interruption of
apoptosis by Epstein Barr virus or Chlamydia prolongs host cell
survival but enhances pathogenesis [20,21]. This dichotomy of
beneficial vs. harmful effects of disrupting apoptosis is reflected in
the innate immune response to infection where leukocytes clear
bacteria, but then apoptosis of phagocytes promotes immune
resolution and wound repair [22,23]. Therefore the timing of
survival factor expression in phagocytes would be expected to be
critical to both successful elimination of the pathogen and
resolution of inflammation.
Spontaneous apoptosis is known to be a major determinant of
the short neutrophil life span [24,25]. Neutrophils in culture die
rapidly, but when incubated with interleukins survive longer (t K
35 vs. 115 h). Early in infection, neutrophil survival is promoted
through the upregulation of Mcl-1 (Bcl-2 pro-survival member),
which allows cells to survive longer in septic patients [26].
Increased survival also occurs if neutrophils are incubated with
specific bacterial components, an effect mediated through
apoptotic prevention [27]. While extended survival of phagocytes
ensures an adequate number of cells to respond to infection, once
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apoptotic genes are downregulated with the resultant induction of
apoptosis. This process promotes resolution of inflammation
through neutrophil clearance by resident macrophages and
increased expression of the anti-inflammatory cytokines TGF-b
and interleukin-10 [15,22]. Despite decades of investigation, many
of the mechanisms controlling the cell fate decisions of these
important innate cells remain elusive. We sought to map the role
of pro-apoptotic factors in specific functions of neutrophils during
the course of infection using a model of acute pneumonia and
sepsis caused by Streptococcus pneumoniae, a gram-positive invasive
bacterium. Here we report that, despite dramatic protection
against DNA damage, the loss of either Puma or p53 is associated
with a shift to overwhelming lethal sepsis in the context of bacterial
infectious diseases.
Results
Loss of Puma compromises control of pneumococcal
infection
Since Puma-deficient mice are protected against the lethal effects
of DNA damage, we sought to determine if the same advantage
was conferred in the context of an infectious challenge. S.
pneumoniae T4 was inoculated intratracheally into Puma
+/+ and
Puma
2/2 mice and the course of pneumonia and sepsis was
followed over 7 days. While 80% of the Puma
+/+ mice survived the
challenge, Puma
2/2 animals died rapidly with 50% succumbing by
48 hours and 84% by 96 hours (Figure 1A, p#0.002). Mean
blood titers were 1000 fold greater in Puma
2/2 mice compared to
Puma
+/+ animals (Figure 1B); 84% of Puma
+/+ animals had
negative blood cultures compared to only 18% of Puma
2/2 mice.
Aggressive progression of infection in Puma
2/2 mice was
documented further using in vivo Xenogen imaging to detect
the spread of bioluminescent S. pneumoniae T4X. While Puma
+/+
mice rarely displayed pneumonia or sepsis, infection disseminated
rapidly in Puma
2/2 mice (Figure 1C).
To determine if the survival defect in the Puma-deficient mice
occurs during a viral infection, Puma
+/+ and Puma
2/2 mice were
infected intranasally with varying infectious doses of influenza A
and assayed for mortality and weight loss. There were no
observable differences between the Puma
2/2 mice when compared
to Puma
+/+, suggesting that Puma-deficiency is not contributing an
important role during influenza infection (Figure S1).
One possible basis for the failure to control bacterial infections
in Puma
2/2 mice could involve poor neutrophil recruitment to the
lungs following bacterial inoculation. As described previously
[7,8], circulating neutrophil and lymphocyte numbers were
equivalent in Puma
+/+ and Puma
2/2 animals (Figure S2). Enume-
ration of leukocytes in bronchoalveolar lavage fluid indicated
equivalent recruitment of macrophages and neutrophils to the
lung 36 hours post infection in both genotypes. Furthermore, both
intraperitoneal injection of thioglycollate or casein or direct
inoculation of S. pneumoniae into the cerebrospinal fluid resulted
in cellular influx to the same order of magnitude and with the
same kinetics between Puma
+/+ and Puma
2/2 animals (data not
shown). These results indicate that loss of Puma had no effect on
phagocyte recruitment to sites of inflammation in response to a
variety of stimuli.
Although neutrophils were rapidly recruited to sites of infection
in Puma
+/+ and Puma
2/2 mice, histopathology indicated gross
differences in the distribution of cells during pneumococcus
infection. Lungs of Puma
+/+ mice demonstrated modest intra-
alveolar inflammation with preservation of lung architecture
(Figure 2, A and B), while Puma
2/2 mice exhibited fibrinopurulent
pleuritis, extensive consolidation and loss of alveolar integrity with
several mice demonstrating an accumulation of leukocytes and
bacteria in prominent abscesses (Figure 2, E and F). Additionally,
we evaluated lung histology during intratracheal infection with an
alternate bacterial pathogen, Staphylococcus aureus, and determined
that the infected Puma
2/2 mice were again more prone to abscess
development than the Puma
+/+ infected mice (4.5 lesions/mouse
vs. 2 lesions/mouse) (Figure 2, C and D vs. G and H). During
pneumococcal infection, spleens from Puma
2/2 mice demonstrat-
ed greater density of neutrophils (Figure 2, L-N) when compared
to those from Puma
+/+ animals (Figure 2, I-K) as confirmed by
staining for myeloperoxidase and neutrophil 7/4 antigen. These
findings are consistent with either decreased clearance of
leukocytes from the tissues of Puma-null mice or a site of secondary
infection.
Increased mortality in mice deficient in the p53-Puma
signaling pathway
To further elucidate the role of Puma-induced apoptosis during
pneumococcal infection, mice deficient in the upstream effector
proteins ATM and p53 were challenged intranasally with
pneumococci and assayed for survival. Similar to the Puma
2/2
mice, p53
2/2 and ATM
2/2 mice demonstrated increased lethality
during bacterial infection (Figure 3A p#0.031 and 3B, p#0.0072
respectively). These findings further suggest that direct regulators
of p53 activation/stabilization and its apoptotic pathway are
essential for host survival during pneumococcal infection.
Role of hematopoietic cells in aggressive sepsis in
Puma
2/2 mice
The central role of hematopoietic cells in the aggressive sepsis in
Puma
2/2 mice was confirmed by bone marrow transplantation.
Lethally irradiated mice were transplanted with either Puma
+/+ or
Puma
2/2 bone marrow. Bone marrow engraftment was confirmed
at 8 weeks by flow cytometric analysis of B cells, T cells and
myeloid cells and by complete blood counts to confirm that white
blood cells, platelets and hemoglobin were restored to normal
values (data not shown). Mice were then challenged intranasally
with bioluminescent S. pneumoniae. Seven of eleven Puma
2/2 mice
Author Summary
Protection against fulminant, lethal bacterial sepsis re-
quires a robust and rapid response from the neutrophil
subclass of white blood cells. However, prolonged survival
of these activated cells leads to organ damage. The cellular
processes determining the optimal life span of neutrophils
are not understood. The p53/Puma pathway drives
programmed cell death by initiating apoptosis. This
response is beneficial in preventing cellular transformation
by eliminating abnormal cells that have sustained DNA
damage. Here we demonstrate an opposing effect of the
pathway in the context of a successful immune response
to bacterial sepsis. Puma
2/2 mice rapidly died when
challenged with bacteria and sites of infection accumulat-
ed large abscesses. Blocking p53/Puma-induced apoptosis
during infection prolonged the life of the CD49d+
neutrophil subpopulation, resulting in insufficient immune
resolution. This study expands the biological role of p53/
Puma-induced apoptosis to the proper clearance of
bacteria by neutrophils and exposes a counter-balance
between the innate immune response to infection and
survival from DNA damage.
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48 hours post-infection compared to two of twelve Puma
+/+ mice
(Figure 3C). All Puma
2/2 mice died by 7 days while 35% of Puma
+/+
mice survived long term. These results suggest the Puma
2/2
immune defect in response to infection is intrinsic to a cell type
originating from the bone marrow compartment.
Phagocytosis and release of DNA NETs by Puma
2/2
neutrophils
The failure of Puma
2/2 animals to contain bacterial pathogens,
despite the presence of neutrophils in the infected tissue, could
indicate a defect in bacterial phagocytosis. To test the efficacy of
bacterial uptake and killing, peritoneal-recruited neutrophils and
macrophages were incubated with FITC-labeled S. pneumoniae and
bacterial/leukocyte association was quantified by fluorescence-
activated cell sorting (FACS) analysis (Figure 4A and data not
shown). Leukocytes from both Puma
+/+ and Puma
2/2 mice
accumulated fluorescence intensity with the same kinetics and
magnitude over one hour while leukocytes incubated at 4uCo r
with cytochalasin D to inhibit phagocytosis did not (Figure 4A,
data not shown). Confocal microscopic images clearly demon-
strated the presence of intracellular pneumococci in both Puma
+/+
and Puma
2/2 neutrophils (Figure 4B). Furthermore, Puma
2/2
neutrophils and macrophages phagocytosed and killed S. pneumo-
niae as efficiently as Puma
+/+ cells upon in vitro incubation with
opsonized bacteria (.95.0% bacteria killed by one hour, data not
shown).
In addition to phagocytosis, neutrophils release neutrophil
extracellular traps (NETs) made of DNA and granules to entrap
and clear extracellular bacteria [28]. To measure NET produc-
tion, Puma
+/+ and Puma
2/2 peritoneal leukocytes were stimulated
with either hydrogen peroxide, pneumococci, or PMA (100 nM).
For both genotypes up to 70% of cells produced NETs (Figure 4C).
In all, these results indicate that Puma-null neutrophils are
functionally equivalent to Puma
+/+ with regards to migration,
phagocytosis, release of NETs and bactericidal activity.
Assessment of neutrophil apoptotic potential
Neutrophils are terminally differentiated cells destined to
undergo programmed cell death within 1 to 2 days after arriving
at sites of infection. Apoptotic neutrophils are then cleared by
macrophages to resolve inflammation [22]. This organized
removal of dying neutrophils prevents the release of cytotoxic
components including granules, lysosomal contents, and reactive
Figure 1. Puma-deficient mice are sensitive to pneumococcal lung infections. (A) Survival curves of Puma
+/+ (solid line; n=19) and Puma
2/2
mice (dashed line: n=18) after intratracheal inoculation of S. pneumoniae T4 (1610
4 cfu); p#0.0002. Data are pooled from two experiments.
(B) Mean bacterial titers in the blood of mice 24 hours after pneumococcal challenge as in A. Symbols represent individual mice; p#0.0063.
(C) Representative Xenogen images of mice challenged with luciferase-expressing S. pneumoniae T4X demonstrating rapid bacterial dissemination and
sepsis in Puma
2/2 compared with Puma
+/+ animals. Color bar of luminescence intensity correlates with bacterial density.
doi:10.1371/journal.ppat.1001240.g001
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observed excess accumulation of leukocytes in lung abscesses and
spleens in Puma
2/2 mice suggested a potential defect in neutrophil
cell death and clearance. Given Puma’s pro-apoptotic role, we
hypothesized that neutrophils from Puma
2/2 mice would be
defective in apoptosis, and thereby show decreased clearance from
infected tissues. To test this hypothesis, Puma
+/+ and Puma
2/2
mice were challenged with S. pneumoniae and bronchoalveolar
lavage fluid was harvested 36 hours post-infection and assessed by
FACS analysis for cell type and viability in five leukocyte subsets.
A panel of antibodies to cell specific markers was applied to
identify neutrophils (Gr-1, Mac-1 and CD49d), macrophages (F4/
80), B cells (IgM/B220), dendritic cells (CD11c/Mac-1) and T
cells (CD4/CD8). Each population was assessed for apoptosis by
Annexin-V/DAPI staining. The subset of neutrophils bearing
CD49d
+, which is suggested to be critical for bacterial clearance
[29], showed ,50% less apoptosis in the Puma
2/2 mice compared
to wild-type mice in two independent experiments consisting of
five mice for each genotype (Figure 5A). Additionally, macro-
phages from Puma
2/2 mice consistently showed a 10% lower rate
of apoptosis compared to Puma
+/+ animals (Puma
+/+ 5561%
apoptotic cells vs. Puma
2/2 4362%, data not shown). These
results suggest that Puma-deficient mice exhibit diminished
apoptosis in a restricted neutrophil and macrophage population
during pneumococcal infection. Consistent with the extended
survival of the Puma
2/2 CD49d
+ subpopulation of neutrophils,
significantly more CD49d positive cells accumulated in infected
lungs and abscesses were positive for CD49d cells (data not
shown).
To examine the relationship between Puma and the viability
and function of neutrophil subtypes in greater detail, we used two
ex vivo culture systems. First, apoptotic resistance and bacterial
killing were examined in primary bone marrow neutrophils.
Briefly, neutrophils from Puma
+/+ and Puma
2/2 bone marrow
were exposed to pneumococci in culture. Neutrophil viability was
assayed by staining with Annexin V/Propidium iodide and
bacterial killing was assessed by culture. Puma
2/2 neutrophils
were consistently ,30% more resistant than Puma
+/+ cells to
apoptosis following incubation with bacteria (Figure S4A).
Focusing specifically on the CD49d
+ population, bacterial killing
was equivalent in both Puma
+/+ and Puma
2/2 cells (Figure S4B).
Secondly, the role of Puma in neutrophil development was
characterized ex vivo using immortalized wild type, Puma
2/2 or
p53
2/2 bone marrow progenitor cells. Cells were immortalized
with an estrogen-regulated hoxb8 gene and grown in stem cell
factor media to promote differentiation towards the neutrophil
lineage [30]. Removal of estrogen induced the hematopoietic
progenitors to differentiate into mature neutrophils over the course
of several days (Figure S3A). Expression of neutrophil cell surface
molecules (Gr-1, Mac-1 and CD49d) was verified by flow
Figure 2. Histopathology of bacterial-infected organs. (A–H) Representative H & E stained lung sections from Puma
+/+ and Puma
2/2 mice at
36 hours post intranasal challenge with S. pneumoniae (A and E: magnification 26; B and F: 106)o rStaphylococcus aureus (C and G: 46; D and H:
106). Arrows identify abscesses. (I–N) Spleen sections from infected mice: H&E stain (I and L); myeloperoxidase stain (J and M), and neutrophil 7/4
antigen stain (K and N) (magnification 306). Representative sections from 4 Puma
+/+ and 3 Puma
2/2 mice.
doi:10.1371/journal.ppat.1001240.g002
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Both the timing and intensity of expression of these phenotypic
markers was essentially identical between wild type and gene
deficient cells (Figure S3B and data not shown). One potential
mechanism where Puma could exert an anti-apoptotic effect in
activated neutrophils is during oxidative stress, since Puma is a
dominant regulator of apoptosis in neurons under similar
conditions [31]. Oxidative stress can be triggered in neutrophils
during pneumococcal infection from two primary sources: a) the S.
pneumoniae pathogen itself is known to express significant levels of
hydrogen peroxide [12,13]; b) neutrophils produce super oxide
radicals utilizing the NADPH oxidase complex resulting in
increased hydrogen peroxide production, which is essential to
the neutrophil’s antibacterial activity [32]. To challenge the role of
Puma in oxidative stress induced apoptosis, we treated the
immortalized progenitor neutrophils with increasing concentra-
tions of hydrogen peroxide. The Puma
2/2 and p53
2/2 Gr1/
CD49d neutrophils were significantly more resistant to this
apoptotic stimulus than the wild type cells (Figure 5B). We also
treated bone marrow neutrophils with phorbol 12-myristate 13-
acetate (PMA, 50 ng/ml), which induces neutrophil apoptosis
through respiratory burst and the production of superoxide and
hydrogen peroxide [33–35]. Initially, we verified that Puma
+/+ and
Puma
2/2 neutrophils were equivalent in the production of
superoxide following PMA treatment by monitoring the oxidation
of dihydrorhodamine 123 into rhodamine 123 and flow cytometry
(Figure S5). Treatment of these cells with 2000 U of catalase, an
enzyme that converts hydrogen peroxide into water, reduced the
levels of superoxide and prevented cell death (Figure S5, and data
not shown). We then treated bone marrow neutrophils from
Puma
+/+ and Puma
2/2 mice with PMA, and determined by flow
cytometry that loss of Puma significantly reduced the number of
apoptotic neutrophils (,50%) compared to wild type under
differing concentrations of PMA or at varied time points
(Figure 5C and data not shown). The involvement of Puma in
neutrophil apoptosis was limited to oxidative stress, since
treatment with Fas or staurosporine yielded equivalent cell death
responses (data not shown).
Discussion
Cells from Puma
2/2 animals and derivative primary knockout
cells are remarkably resistant to apoptosis induced by a variety of
insults including ionizing radiation, steroid treatment, hypoxia,
and cytokine withdrawal. To be maintained in the genome, these
apoptotic regulators must provide a survival advantage in response
to a more frequently encountered lethal insult. Our results indicate
that Puma, ATM and p53 play an essential role in the innate
Figure 3. Survival of pneumococcal-infected mice deficient in p53 signaling factors. (A) Isogenic wild type (solid, n=17) and p53
2/2
(dashed, n=18) mice were challenged with pneumococci intranasally and survival was monitored for 7 days (p#0.031) (mean 6 SD, n=3). (B)
Isogenic wild-type (solid, n=12) and ATM
2/2 (dashed, n=11) mice were infected intratracheally with pneumococci and monitored for survival for 7
days (p#0.0072). (C) Wild-type mice reconstituted with Puma
+/+ or Puma
2/2 bone marrow were analyzed by Xenogen imaging at 48 hours post-
intranasal inoculation of S. pneumoniae T4X. Red indicates high titer bacterial pneumonia.
doi:10.1371/journal.ppat.1001240.g003
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PLoS Pathogens | www.plospathogens.org 5 December 2010 | Volume 6 | Issue 12 | e1001240Figure 4. Functional analysis of neutrophil phagocytosis and NETs production. (A) Flow cytometry histograms for uptake of FITC-labeled
pneumococci into peritoneal neutrophils (100:1) over 1 hour at 37uC (green and red) or on ice (purple and blue). Shift to the right along the x axis
(arrow) indicates bacterial uptake by cells. Right panel is overlay of histograms from Puma
+/+ and Puma
2/2 neutrophils incubated with bacteria at
37uC. (B) Confocal micrographs of leukocytes from panel A stained with Vybrant DiD (cytoplasm; red) and DAPI (nucleus; blue) after phagocytosis of
FITC-labeled pneumococci (green). Magnification 1006. (C) Production of neutrophil extracellular traps (NETs [DNA stained blue by DAPI]: arrows
indicate bacteria in NET’s) by Puma
+/+ and Puma
2/2 neutrophils exposed to FITC-labeled pneumococci for 3 hours. Magnification 46.
doi:10.1371/journal.ppat.1001240.g004
Neutrophil Puma Protects against Sepsis
PLoS Pathogens | www.plospathogens.org 6 December 2010 | Volume 6 | Issue 12 | e1001240Figure 5. Pneumococcal-induced apoptosis of leukocyte subpopulations. (A) Percent apoptosis (AnnexinV/DAPI-positive cells) of neutrophil
subpopulations from wild type (white bars) and Puma
2/2 (black bars) mice with indicated markers harvested by bronchial lavage of mice at 36 hours
post-infection with S. pneumoniae T4 (data combines two independent experiments each with five pooled mice from both genotypes). (B) Percent
apoptosis (Annexin V/propidium iodide positive) of wild type (black bars), Puma
2/2 (white bars), and p53
2/2 (grey bars) progenitor cells differentiated
for72 hours andexposed toindicatedconcentrationofhydrogenperoxidefor3.5 hours (mean 6SD of3 experiments). ** = significantlydifferent from
wild type at p#0.007 for Puma and ,0.005 for p53. (C) Percent apoptosis (Annexin V/7-AAD positive) of wild type and Puma
2/2 bone marrow
neutrophils treated four hours with 50 ng/ml PMA (mean 6 SD of 6 experiments) *** = significantly different from wild type at p#0.0009.
doi:10.1371/journal.ppat.1001240.g005
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of them, mice are extremely sensitive to these challenges.
Upon pneumococcal challenge, Puma
2/2 mice display striking
lethality with 50% of challenged animals succumbing by 48 hours
and average blood bacterial titers 3 logs higher than seen with wild
type mice. This indicates an almost complete inability to control
bacterial replication in the lungs of these mice, which is contrary to
the observations made in the Bim
2/2 mouse (closely related BH3-
only protein), since those mice appear to be more resistant to
bacterial sepsis [36]. In the context of apoptosis resistance, Bim
and Puma often display redundant functions during a variety of
cellular insults. However, our data clearly demonstrates a drastic
difference between these related BH3-only proteins. Thus, Puma
and Bim appear to play opposing critical roles in the innate
immune response to facilitate bacterial clearance.
Our bone marrow transplant experiments indicate that Puma’s
influence on outcome of infection is intrinsic to hematopoietic cells
that arise from the bone marrow compartment. Of the cells
originating there, neutrophils were our primary focus since they
are recruited in large numbers early in response to bacterial
infection and since apoptosis of neutrophils is thought to be
important during the resolution of infection [22]. Functional
studies with neutrophils from Puma
2/2 mice indicated that these
cells are competent in normal functions such as phagocytosis,
bacterial killing, and NET formation. These results argue that the
uncontrolled bacterial growth and overwhelming sepsis seen in
these mice are not due to non-functional neutrophils. This taken
together with the formation of abscesses in the lungs and
accumulation of cells in the spleen of Puma
2/2 mice points to
an unregulated resolution of the innate response to infection. In
addition, neutrophils which are unable to undergo normal
apoptosis are more likely to degranulate or die of necrosis, both
of which contribute to inflammation and damage to host tissues.
Necrotic neutrophils and a dysregulated inflammatory response
could also allow release of phagocytosed but viable bacteria and
increase vascular permeability, thereby enhancing progression to
sepsis. Consistent with our findings in the context of lack of
expression of a pro-apoptotoic factor, Koedel et al. recently
demonstrated that constitutive expression of the anti-apoptotic
factor Bcl-2 led to persistent neutrophil brain infiltrates in
meningitis and more severe disease [37]. These findings link the
expression of an apoptosis-regulating protein with control of
inflammation during pyogenic infection.
Bronchial lavages of infected Puma
+/+ and Puma
2/2 mice
indicated a marked difference in apoptosis restricted to the
subpopulation of neutrophils expressing CD49d and to a lesser
extent, in macrophages. Other cell types were not affected,
indicating that determination of cell fate in the majority of
leukocytes is independent of Puma but vital to determining the
lifespan of the small subset of CD49d
+ leukocytes. This effect
appears to be independent of the ability of these cells to kill
bacteria. CD49d is an alpha chain integrin (VLA-4) strongly
expressed early in granulocyte maturation and this expression
decreases during terminal maturation [38]. Additionally, CD49d
has been localized to leukocytes associated with neutrophil
extravasation into the interstitial spaces of lungs during acute
lung injury upon bacterial infections [39]. Tsuda et al demon-
strated that the specific subpopulation of neutrophils characterized
by expression of CD49d is required for resistance to Staphylococcus
aureus infection [29]. Taken together our results corroborate the
findings of Tsuda et al. suggesting a possible role for the CD49d
subset of neutrophils during bacterial challenge.
Puma’s involvement with DNA damage pathways may relate to
its importance in protection against bacterial challenge. Activated
neutrophils express large amounts of reactive oxygen species,
particularly hydrogen peroxide and the hydroxyl radical. These
oxidative agents are cell permeable and are known to induce cell
death. Pneumococci also produce large quantities of hydrogen
peroxide as a by-product of their metabolism in amounts
comparable to that generated by neutrophils [40]. We demon-
strated that Puma
2/2 neutrophils are more resistant to cell death
when either exposed to hydrogen peroxide or when they are
activated to produce hydrogen peroxide. Therefore, heightened
ROS expression could be a signal that induces apoptosis in normal
neutrophils while Puma
2/2 cells survive. ROS induced DNA-
damage has been shown to trigger p53 cell death pathways and
this response involved hydrogen peroxide production [41,42]. It
stands to reason that a short lived cell type that is predestined to
undergo apoptosis and capable of expressing large amounts of
ROS would utilize a DNA damage-induced pathway for
programmed cell death. In support of this notion Marriott et al.
recently reported that the NADPH oxidase deficient gp91(phox)
2/2
mice, which have limited ROS production, displayed a significant
decrease in apoptosis of neutrophils recruited to lungs during
bacterial pneumonia [43]. This suggests that decreased ROS
production may lead to neutrophil survival, however, the
diminished apoptosis does not lead to increased tissue damage
and sepsis as seen in our model. It is feasible the ROS produced by
the pathogen induces enough neutrophil cell death allowing for
proper clearance of resident apoptotic neutrophils and a sustainable
anti-inflammatory response. Therefore, only during a unique
situation of pathogen challenge might the importance of such
duplicity be revealed.
The importance of the DNA-damage response pathway in
infection is underlined by the fact that deficiency of other proteins
comprising this pathway results in a similar phenotype. We
demonstrate that both p53
2/2 and ATM
2/2 mice are severely
defective in controlling pneumococcal infection. These proteins
both function upstream of Puma to initiate Puma-induced
programmed cell death. These results bring to light a novel
function for a well-characterized pathway that will significantly
enhance our understanding of the innate immune response in the
context of bacterial infections.
Materials and Methods
Bacterial strains and growth conditions
Streptococcus pneumoniae strains used included: serotype 4 clinical
isolate TIGR4 (T4), T4R (unencapsulated mutant of TIGR4), and
T4X (luciferase-expressing TIGR4). All pneumococcal strains
were grown on tryptic soy agar plates supplemented with 3%
sheep blood and appropriate antibiotics at 37uCi n5 %C O 2
overnight before being transferred to a defined semisynthetic
casein liquid medium supplemented with 0.5% yeast extract
(Sigma). Antibiotics were used at the following concentrations:
chloramphenicol (5 mg/ml; Sigma) and kanamycin (400 mg/ml;
Sigma). Liquid cultures were grown without aeration at 37uCi n
5% CO2 incubator to OD620 of 0.4 or 0.5. Staphylococcus aureus
NRS193 were streaked onto blood agar plates and grown
overnight at 37uC. Plates were then scraped and washed with
brain heart infusion media (BD Biosciences) containing 25%
glycerol and frozen as concentrated stocks until used for infections.
Animal techniques
Wild type, p53
2/2 (NM_011640), Puma
2/2 (NM_133234) and
ATM
2/2 (NM_007499) mice (C57BL/6 or C57B/6/SV129
background) were anesthetized with isoflurane and challenged
either intranasally (25 ml) or intratracheally (100 ml) with T4 or
Neutrophil Puma Protects against Sepsis
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of disease was followed for up to 7 days [44]. To quantify sepsis,
blood samples were serially diluted in phosphate buffered saline
(PBS) and plated on tryptic soy blood agar plates.
For some experiments, mice were sacrificed at 36 hours and
bronchoalveolar lavage was harvested and analyzed by flow
cytometry for apoptotic cells by staining with Annexin V,
propidium iodide, or DAPI (Vector Laboratories). Cell types were
enumerated by reactivity with a panel of antibodies specific to
neutrophils (Gr-1, Mac-1 and CD49d: BD Biosciences, San Jose,
CA), macrophages (F4/80: eBioscience, San Diego, CA), B cells
(IgM/B220: SouthernBiotech, Birmingham, AL; BD Biosciences,
San Jose, CA), dendritic cells (CD11c/Mac-1: BD Biosciences,
San Jose, CA) and T cells (CD4/CD8: BD Biosciences, San Jose,
CA). Apoptosis was assessed by flow cytometry using Annexin V
(BD Biosciences, San Jose, CA) and DAPI (Invitrogen, Carlsbad,
CA) Lungs and spleens were examined for neutrophil infiltration
by immunohistochemical staining for CD49d (eBioscience, San
Diego, CA), myeloperoxidase (Dako, Carpinteria, CA) and the
neutrophil differentiation antigen 7/4 (Invitrogen, Carlsbad, CA).
For S. aureus infections, bacterial stocks were diluted to
2.4610
9 cfu/ml and given intratracheally to mice in 100 ml
volumes. Mice were followed for survival or sacrificed at 48 hours
and lungs were removed for immunohistochemistry staining.
Abscesses were quantified by light microscopy examination of
multiple whole lung sections from both Puma
+/+ and Puma
2/2
mice by a pathologist blinded to the experimental design.
Bone marrow transplantation
C67BL/6 mice (Jackson Laboratories) were lethally irradiated
with 11 Gy of gamma irradiation and reconstituted with 1610
7
Puma
+/+ and Puma
2/2 bone marrow cells/mouse by retro-orbital
injection. Mice were assayed at 8 weeks for bone marrow
engraftment by complete blood counts, flow cytometry analysis
of T cells (CD4+/CD8+), B cells, neutrophils and macrophages as
well as RT-PCR for Puma deletion. Fully reconstituted mice were
infected intranasally with 1610
7 T4X and assayed for survival and
bacterial presence by Xenogen imaging.
Isolation of peritoneal macrophages, peritoneal and bone
marrow neutrophils C57BL/6 mice were injected intraperitone-
ally with 1 ml 10% casein (Sigma) and neutrophils were isolated at
2 hours or 24 hours by peritoneal lavage using Hank’s balanced
salt solution (HBSS) without Ca+ or Mg+ (Invitrogen) followed by
red blood cell lysis in ACK buffer (0.15 M NH4Cl, 10 mM
KHCO3, 0.1 mM Na2EDTA; Sigma). Isolated peritoneal neutro-
phils were washed in Iscoves Modified Dulbecco’s medium
(Invitrogen) and quantified. Bone marrow neutrophils were
prepared from murine femurs using discontinuous Percoll
gradients (Amersham Pharmacia Biotech) as previously described
[45]. Macrophages were recruited to the peritoneal cavity by IP
injection of 4% thioglycollate and isolated three days post-injeciton
by peritoneal lavage.
Immortalization of neutrophil progenitors
Puma
+/+ and Puma
2/2 bone marrow cells were expanded for
two days in RPMI-1640 (Invitrogen) containing 10% fetal bovine
serum (FBS; Hyclone), 10 ng/ml stem cell factor (SCF; from cell
culture supernatant), 10 ng/ml Interleukin 3 (Peprotech) and
20 ng/ml Interleukin 6 (Peprotech) and infected with a murine
stem cell virus -based retrovirus expressing estrogen-regulated
Hoxb8 as previously described [30]. Transduced non-adherent
cells were serially passaged in RPMI containing 10% FBS, 1%
penicillin-streptomycin, 10 ng/ml SCF and 1 mM b-estradiol
(Sigma) to expand for immortalized myeloid progenitors for 20
days, by which time control marrow cultures had stopped dividing.
Progenitors were induced to undergo differentiation into neutro-
phils upon b-estradiol removal and culturing in the presence of
SCF. Bacterial phagocytosis/lysis assays Murine neutrophils were
isolated by peritoneal lavage 24 hours after injection of 10%
casein (Sigma). After red cell lysis (see above), neutrophils were
resuspended in HBSS with Ca
2+ and Mg
2+ modified with 0.1%
gelatin (Sigma) and 10% fresh mouse serum, followed by a 1 hour
rotated incubation at 37uCo r0 uC with various ratios of FITC-
labeled-bacteria:neutrophils as described in the text. Phagocytosis
was assessed by flow cytometry quantitating FITC+ cells. Results
were confirmed by visualizing FITC labeled bacteria in cells
stained with Vybrant DiD (Invitrogen) and DAPI using fluores-
cence microscopy. Bacterial was determined by washing the
neutrophils in PBS, lysing the cells in sterile H2O and determining
bacterial growth from serial dilutions of lysates grown on blood
agar plates [46].
Ex vivo neutrophil characterization
Purified bone marrow neutrophils from Puma
+/+ or Puma
2/2
mice were suspended in HBSS with Ca
2+ and Mg
2+ modified with
0.1% gelatin and incubated for 1 hour with serum opsonized S.
pneumoniae T4R at bacteria/neutrophil ratios of 1:10, 1:1, or 5:1.
Cells were then washed in PBS with 1% FBS, resuspended in
RPMI-1640 supplemented with 10% FBS and incubated at 37uC
in 5% CO2 for 3 hours. 3610
6 neutrophils were washed and
stained for 15 min with Annexin V-FITC (BD Biosciences).
Propidium iodide (BD Biosciences) was added and cells were
analyzed by FACS for specific apoptosis. Specific apoptosis was
calculated by the formula: (test – control)/(100 – control) 6100.
The test sample was incubated with bacteria while the control
received no bacteria but was otherwise treated identically.
NET characterization
Peritoneal neutrophils were recruited by intraperitoneal injec-
tion of 10% casein (Sigma) and harvested by peritoneal lavage.
The cells were washed and resuspended in PBS with Ca
2+ and
Mg
2+ (Invitrogen), and allowed to adhere for 20 min. to poly-L-
lysine coated coverslips (Sigma-Aldrich) in 6-well plates. Neutro-
phils were then treated with either serum-opsonized heat killed S.
pneumoniae T4R (100 bacteria/neutrophil; labeled with FITC) or
H2O2 (125 mM; Sigma) for 3 hours or PMA (100 nM) for
16 hours in RPMI media with 10%FBS. After stimulation, cover
slips were fixed with 3% paraformaldehyde and mounted onto
slides with DAPI-Vectormount (Vector Labs) or PL2-3 anti-
histone antibody (courtesy of Dr. A Zychlinsky). DNA stained
NETs were visualized with a fluorescence microscope.
H2O2 stress-induced apoptosis
Immortalized neutrophil progenitors were washed free of
estrogen and allowed to differentiate for 3 days. Cells were then
washed with fresh RPMI and suspended at 5610
5 cells/ml in 2 ml
RPMI (10% FBS) containing hydrogen peroxide (Sigma) at 0, 10,
60, or 120 mM for 3.5 hours. Cells were then washed once with
PBS (1% FBS), stained with Annexin V and propidium iodide and
assayed by flow cytometry for apoptosis.
Bone marrow neutrophils were isolated (described above) and
treated in vitro for 30 minutes or four hours with 50 ng/ml
phorbol 12-myristate 13-acetate (Sigma-Aldrich) in RPMI 1640
medium supplemented with 10% fetal bovin serum (Hyclone),
2 mM L-glutamine and penicillin (100 IU/ml) and streptomycin
(100 ug/ml) at 37uCi n5 %C O 2. Cells were assayed by flow
cytometry for superoxide production using Dihydrorhodamine
123 (Calbiochem) or for apoptosis by Annexin V/7-Amino
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curves were tested for significant difference utilizing the logrank
test. Additional statistical analyses were performed by the
Student’s t-test. In all cases, p,0.05 was considered as statistical
significance.
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Supporting Information
Figure S1 Influenza infection of Puma
+/+ and Puma
2/2 mice.
Mice were infected intranasally with the indicated doses of
influenza strain X31 and followed for survival and weight loss over
time (Puma
+/+: (WT) solid line; Puma
2/2: (KO) dashed line). Each
line is an individual mouse.
Found at: doi:10.1371/journal.ppat.1001240.s001 (0.12 MB TIF)
Figure S2 Quantification of neutrophils and macrophages from
Puma
+/+ and Puma
2/2 mice. Neutrophils (Gr1+/Mac1+) and
macrophages (F480+/Mac1+) were quantified by flow cytometry
from bone marrow and spleen of Puma
+/+ and Puma
2/2 mice
(n=5; p= not significant).
Found at: doi:10.1371/journal.ppat.1001240.s002 (0.13 MB TIF)
Figure S3 Differentiation of Puma
2/2 progenitor cells in vitro.
(A) Wright-Giemsa stained cytospins of Puma
+/+ and Puma
2/2
neutrophil progenitors undifferentiated (+ estrogen) or differenti-
ated (- estrogen) for 3 and 6 days. Multi-lobed nucleus
characteristic of neutrophils is evident upon differentiation. (B)
Flow cytometric histograms of Puma
+/+ and Puma
2/2 neutrophil
progenitors during differentiation demonstrating expression of cell
surface markers Gr-1 and CD49d over time.
Found at: doi:10.1371/journal.ppat.1001240.s003 (2.08 MB
TIF)
Figure S4 Apoptosis and function of neutrophils incubated with
S. pneumoniae. (A) Bone marrow neutrophils (n) were incubated in
different ratios with T4R pneumococcus (b) for 1 hr; 4 hrs later
cells were stained with AnnexinV/Propidium Iodide and quanti-
fied for apoptosis by flow cytometry (mean 6 SD for 4
experiments). Puma
+/+: white bars; Puma
2/2: black bars. Data
are presented as the mean 6 SEM of four independent
experiments: **p#0.008. (B) CD49d+ bone marrow neutrophils
unprimed (TNF-) or primed (TNF+) were incubated with bacteria
for 1 hour at 37uC and the percentage of bacterial killing was
quantitated by culture.
Found at: doi:10.1371/journal.ppat.1001240.s004 (0.06 MB TIF)
Figure S5 Analysis of superoxide production in Puma
+/+ and
Puma
2/2 bone marrow neutrophils. Bone marrow neutrophils
from Puma
+/+ and Puma
2/2 were treated for 30 minutes with
50 ng/ml of PMA, either with or without 2000 U/ml of catalase,
then assayed for the presence of superoxide using dihydrorhoda-
mine 123 and flow cytometry (mean 6 SD of 6 experiments).
Found at: doi:10.1371/journal.ppat.1001240.s005 (0.04 MB TIF)
Acknowledgments
We wish to thank Geli Gao, Yunming Hu and Hope Smith-Sielicki for
excellent technical assistance and P. McKinnon and Chris Dillion for
genetically modified mice. We thank Jon McCullers and Amy Iverson for
the S.aureus strain and procedure. Drs. Arturo Zychlinsky and Garret Hayes
provided the PL2-3 anti-histone antibody and the protocol for visualizing
NETs. Additionally, we would like to thank Darren Phillips for valuable
discussions on this project.
Author Contributions
Conceived and designed the experiments: SPG JAT GPZ EIT. Performed
the experiments: SPG JAT RW EP. Analyzed the data: SPG JAT JER EP
GPZ EIT. Contributed reagents/materials/analysis tools: HH RW. Wrote
the paper: SPG JAT EIT.
References
1. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408:
307–310.
2. Doumont G, Martoriati A, Beekman C, Bogaerts S, Mee PJ, et al. (2005) G1
checkpoint failure and increased tumor susceptibility in mice lacking the novel
p53 target Ptprv. Embo J 24: 3093–3103.
3. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, et al. (1993)
WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817–825.
4. Han J, Flemington C, Houghton AB, Gu Z, Zambetti GP, et al. (2001)
Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell
death and survival signals. Proc Natl Acad Sci U S A 98: 11318–11323.
5. Nakano K, Vousden KH (2001) PUMA, a novel proapoptotic gene, is induced
by p53. Mol Cell 7: 683–694.
6. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B (2001) PUMA induces
the rapid apoptosis of colorectal cancer cells. Mol Cell 7: 673–682.
7. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, et al. (2003) Puma is an essential
mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell
4: 321–328.
8. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, et al. (2003) p53-
and drug-induced apoptotic responses mediated by BH3-only proteins puma
and noxa. Science 302: 1036–1038.
9. Weber JD, Zambetti GP (2003) Renewing the debate over the p53 apoptotic
response. Cell Death Differ 10: 409–412.
10. Nau R, Soto A, Bruck W (1999) Apoptosis of neurons in the dentate gyrus in
humans suffering from bacterial meningitis. J Neuropathol Exp Neurol 58:
265–274.
11. Zychlinsky A, Sansonetti P (1997) Perspectives series: host/pathogen interac-
tions. Apoptosis in bacterial pathogenesis. J Clin Invest 100: 493–495.
12. Braun JS, Novak R, Herzog KH, Bodner SM, Cleveland JL, et al. (1999)
Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 5:
298–302.
13. Braun JS, Novak R, Murray PJ, Eischen CM, Susin SA, et al. (2001) Apoptosis-
inducing factor mediates microglial and neuronal apoptosis caused by
pneumococcus. J Infect Dis 184: 1300–1309.
14. Odio CM, Faingezicht I, Paris M, Nassar M, Baltodano A, et al. (1991) The
beneficial effects of early dexamethasone administration in infants and children
with bacterial meningitis. N Engl J Med 324: 1525–1531.
15. Kobayashi SD, Deleo FR (2004) An apoptosis differentiation programme in
human polymorphonuclear leucocytes. Biochem Soc Trans 32: 474–476.
16. Zychlinsky A, Prevost MC, Sansonetti PJ (1992) Shigella flexneri induces
apoptosis in infected macrophages. Nature 358: 167–169.
17. Marriott HM, Dockrell DH (2006) Streptococcus pneumoniae:the role ofapoptosis
in host defense and pathogenesis. Int J Biochem Cell Biol 38: 1848–1854.
18. Komarova EA, Krivokrysenko V, Wang K, Neznanov N, Chernov MV, et al.
(2005) p53 is a suppressor of inflammatory response in mice. Faseb J 19:
1030–1032.
19. Hotchkiss RS, Tinsley KW, Hui JJ, Chang KC, Swanson PE, et al. (2000) p53-
dependent and -independent pathways of apoptotic cell death in sepsis.
J Immunol 164: 3675–3680.
20. Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, et al. (2008) An Epstein-
Barr virus-encoded microRNA targets PUMA to promote host cell survival.
J Exp Med 205: 2551–2560.
21. Fischer SF, Vier J, Kirschnek S, Klos A, Hess S, et al. (2004) Chlamydia inhibit
host cell apoptosis by degradation of proapoptotic BH3-only proteins. J Exp
Med 200: 905–916.
Neutrophil Puma Protects against Sepsis
PLoS Pathogens | www.plospathogens.org 10 December 2010 | Volume 6 | Issue 12 | e100124022. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, et al. (1998)
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory
cytokine production through autocrine/paracrine mechanisms involving TGF-
beta, PGE2, and PAF. J Clin Invest 101: 890–898.
23. Nathan C (2006) Neutrophils and immunity: challenges and opportunities. Nat
Rev Immunol 6: 173–182.
24. Savill JS, Henson PM, Haslett C (1989) Phagocytosis of aged human neutrophils
b ym a c r o p h a g e si sm e d i a t e db yan o v e l" c h a r g e - s e n s i t i v e "r e c o g n i t i o n
mechanism. J Clin Invest 84: 1518–1527.
25. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, et al. (1989)
Macrophage phagocytosis of aging neutrophils in inflammation. Programmed
cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest
83: 865–875.
26. Harter L, Mica L, Stocker R, Trentz O, Keel M (2003) Mcl-1 correlates with
reduced apoptosis in neutrophils from patients with sepsis. J Am Coll Surg 197:
964–973.
27. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A (1992) Modulation of
granulocyte survival and programmed cell death by cytokines and bacterial
products. Blood 80: v2012–2020.
28. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, et al. (2007) Novel cell
death program leads to neutrophil extracellular traps. J Cell Biol 176: 231–241.
29. Tsuda Y, Takahashi H, Kobayashi M, Hanafusa T, Herndon DN, et al. (2004)
Three different neutrophil subsets exhibited in mice with different susceptibilities
to infection by methicillin-resistant Staphylococcus aureus. Immunity 21:
215–226.
30. Wang GG, Calvo KR, Pasillas MP, Sykes DB, Hacker H, et al. (2006)
Quantitative production of macrophages or neutrophils ex vivo using
conditional Hoxb8. Nat Methods 3: 287–293.
31. Steckley D, Karajgikar M, Dale LB, Fuerth B, Swan P, et al. (2007) Puma is a
dominant regulator of oxidative stress induced Bax activation and neuronal
apoptosis. J Neurosci 27: 12989–12999.
32. Segal AW (2005) How neutrophils kill microbes. Annu Rev Immunol 23:
197–223.
33. Hampton MB, Vissers MC, Keenan JI, Winterbourn CC (2002) Oxidant-
mediated phosphatidylserine exposure and macrophage uptake of activated
neutrophils: possible impairment in chronic granulomatous disease. J Leukoc
Biol 71: v775–781.
34. Lundqvist-Gustafsson H, Bengtsson T (1999) Activation of the granule pool of
the NADPH oxidase accelerates apoptosis in human neutrophils. J Leukoc Biol
65: 196–204.
35. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, Fleisher TA (1995) Flow
cytometric analysis of the granulocyte respiratory burst: a comparison study of
fluorescent probes. J Immunol Methods 178: 89–97.
36. Chang KC, Unsinger J, Davis CG, Schwulst SJ, Muenzer JT, et al. (2007)
Multiple triggers of cell death in sepsis: death receptor and mitochondrial-
mediated apoptosis. Faseb J 21: 708–719.
37. Koedel U, Frankenberg T, Kirschnek S, Obermaier B, Hacker H, et al. (2009)
Apoptosis is essential for neutrophil functional shutdown and determines tissue
damage in experimental pneumococcal meningitis. PLoS Pathog 5: e1000461.
38. Lund-Johansen F, Terstappen LW (1993) Differential surface expression of cell
adhesion molecules during granulocyte maturation. J Leukoc Biol 54: 47–55.
39. Burns JA, Issekutz TB, Yagita H, Issekutz AC (2001) The alpha 4 beta 1 (very
late antigen (VLA)-4, CD49d/CD29) and alpha 5 beta 1 (VLA-5, CD49e/
CD29) integrins mediate beta 2 (CD11/CD18) integrin-independent neutrophil
recruitment to endotoxin-induced lung inflammation. J Immunol 166:
4644–4649.
40. Duane PG, Rubins JB, Weisel HR, Janoff EN (1993) Identification of hydrogen
peroxide as a Streptococcus pneumoniae toxin for rat alveolar epithelial cells.
Infect Immun 61: 4392–4397.
41. Ye J, Wang S, Leonard SS, Sun Y, Butterworth L, et al. (1999) Role of reactive
oxygen species and p53 in chromium(VI)-induced apoptosis. J Biol Chem 274:
34974–34980.
42. Huang C, Zhang Z, Ding M, Li J, Ye J, et al. (2000) Vanadate induces p53
transactivation through hydrogen peroxide and causes apoptosis. J Biol Chem
275: 32516–32522.
43. Marriott HM, Jackson LE, Wilkinson TS, Simpson AJ, Mitchell TJ, et al. (2008)
Reactive oxygen species regulate neutrophil recruitment and survival in
pneumococcal pneumonia. Am J Respir Crit Care Med 177: 887–895.
44. Orihuela CJ, Gao G, Francis KP, Yu J, Tuomanen EI (2004) Tissue-specific
contributions of pneumococcal virulence factors to pathogenesis. J Infect Dis
190: 1661–1669.
45. Garrison S, Hojgaard A, Margraf R, Weis JJ, Weis JH (2003) Surface
translocation of pactolus is induced by cell activation and death, but is not
required for neutrophil migration and function. J Immunol 171: 6795–6806.
46. Lysenko ES, Clarke TB, Shchepetov M, Ratner AJ, Roper DI, et al. (2007)
Nod1 signaling overcomes resistance of S. pneumoniae to opsonophagocytic
killing. PLoS Pathog 3: e118.
Neutrophil Puma Protects against Sepsis
PLoS Pathogens | www.plospathogens.org 11 December 2010 | Volume 6 | Issue 12 | e1001240